Related Experiment Video
Updated: Jun 23, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Limited humoral immunity in hepatitis C virus infection
M Chen1, M Sällberg, A Sönnerborg
1Department of Molecular Biology, Scripps Research Institute, La Jolla, California 92037, USA.
Insights
Hepatitis C virus (HCV) infection shows limited antibody responses, primarily IgG1, with low titers and delayed appearance. This suggests HCV may employ an immune avoidance strategy, contributing to chronic infections.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- Hepatitis C virus (HCV) infection frequently leads to chronic disease, indicating an impaired immune response.
- Understanding the humoral immune response is crucial for developing effective treatments and vaccines.
Purpose of the Study:
- To evaluate the humoral immune response to Hepatitis C virus (HCV) in patients with acute and chronic infections.
- To characterize the immunoglobulin (Ig) G antibody isotypes and their specificities against various HCV antigens.
Main Methods:
- Enzyme-linked immunoassays (ELISAs) were employed to detect antibodies against recombinant HCV antigens.
- Antigens included core, envelope 2 (E2), nonstructural (NS) 3, NS4, and NS5 proteins, along with E2-HVR-1 peptides.
Main Results:
- Antibody responses were predominantly restricted to the IgG1 isotype, with high prevalence for core (97%) and E2 (98%) antigens.
- Low antibody titers and delayed appearance of responses (except anti-HCV core) were observed, typically emerging in the chronic phase.
- IgG3, IgG2, and IgG4 isotypes were detected infrequently, suggesting a skewed humoral immune response.
Conclusions:
- The limited immunogenicity of HCV proteins during natural infection, characterized by IgG1 restriction, low titers, and delayed responses, contributes to chronicity.
- The findings suggest that Hepatitis C virus may utilize an "immune avoidance" strategy to evade effective host immunity.
- Further research into HCV immune evasion mechanisms is warranted to inform therapeutic strategies.
Background & Aims:
The extremely high rate of chronicity to hepatitis C virus (HVC) infection suggests an inefficient immune response. The humoral immune response to HCV was evaluated in 60 patients with chronic HCV infection and in 12 patients acutely infected with HCV.
Methods:
A number of recombinant HCV antigens including the core, envelope 2 (E2), nonstructural (NS) 3, NS4, and NS5 proteins, and NS4a and E2-HVR-1 peptides were used in enzyme-linked immunoassays.
Results:
Immunoglobulin (Ig) G antibody responses to these viral antigens, except for the HCV core, were highly restricted to the IgG1 isotype. The prevalence of antibodies of the IgG1 isotype specific for the HCV core, E2, E2-HVR1, NS3 (helicase domain), NS4, and NS5 antigens was 97%, 98%, 28%, 88%, 33%, and 68%, respectively. Antibodies of the IgG3 isotype specific for E2, E2-HVR-1, NS3, NS4, and NS5 were detected in a minority of serum samples. The IgG2 and IgG4 isotypes were rarely if ever detected. Furthermore, antibody responses to HCV viral antigens were of relatively low titer and, with the exception of anti-HCV core, were delayed in appearance until the chronic phase of infection.
Conclusions:
The IgG1 restriction, low titer, and delayed appearance of antibody responses elicited during HCV infection suggest that the immunogenicity of HCV proteins is limited in the context of natural infection. Inasmuch as recombinant HCV viral antigens perform as relatively normal immunogens in small animals, we suggest that the defective humoral immune responses during HCV infection may be attributable to an "immune avoidance" strategy.
More Related Videos
Related Concept Videos
Humoral Immune Responses
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

